Table 1

Prognostic similarity of groups at baseline

Active ET (n=73)Dummy ET (n=72)No ET/no US (n=35)Active US (n=73)Dummy US (n=72)
Age (mean (sd))51  (14)50  (13)54  (13)50  (13)51  (14)
Female (%)4656515250
Previous episodes (%)
 05650604957
 1–53340263637
 >5111014147
Coexistent disorders
 cervical8878778878
 homolateral elbow2532312532
Impaired shoulder
 dominant5147544553
 left4442344935
Duration (%) (months)
 0 to 34137373839
 3 to 62133262222
 6 to 122215201819
 >121715172210
Pain radiating below elbow (%)7576606785
Caused by trauma (%)81217813
Gradual onset (%)6871636674
Symptoms before inclusion (%)
 increased6773716872
 stable81014711
 decreased2517152517
Prognostic grading1-150 51 (27–68)48 (30–70)39 (25–72)50 (25–70)50 (24–68)
  • US=Ultrasoundtherapy; ET=electrotherapy. Because of the factorial trial design the ET groups and the US groups represent the same patients.

  • 1-150 Prognostic grading by research physiotherapist on a 100 millimetre visual analogue scale (0/100: best/worst), based on a standardised clinical assessment. This assessment involved a standardised history; inspection of contour, muscle wasting and swelling; active and passive evaluation of range of motion and pain on abduction, flexion, internal and external rotation, extension and adduction; evaluation of the functional mobility and active glenohumeral-scapulo-thoracic rhythm; evaluation of joint play and pain on accessory movements; evaluation of muscle weakness and pain on isometric muscle testing; and palpatory assessment of pain and tissue condition. SD=standard deviation, n=number of patients, median (interquartile range).